%0 Journal Article
%T Summary Paper on Underactive Bladder from the European Association of Urology Guidelines on Non-neurogenic Male Lower Urinary Tract Symptoms.
%A Baboudjian M
%A Hashim H
%A Bhatt N
%A Creta M
%A De Nunzio C
%A Gacci M
%A Herrmann T
%A Karavitakis M
%A Malde S
%A Moris L
%A Netsch C
%A Rieken M
%A Sakalis V
%A Schouten N
%A Tutolo M
%A Cornu JN
%J Eur Urol
%V 86
%N 3
%D 2024 Sep 20
%M 38644139
%F 24.267
%R 10.1016/j.eururo.2024.04.004
%X <B>OBJECTIVE: </B>The European Association of Urology (EAU) Guidelines Panel on non-neurogenic male lower urinary tract symptoms (LUTS) aimed to develop a new subchapter on underactive bladder (UAB) in non-neurogenic men to inform health care providers of current best evidence and practice. Here, we present a summary of the UAB subchapter that is incorporated into the 2024 version of the EAU guidelines on non-neurogenic male LUTS.<BR><B>METHODS: </B>A systematic literature search was conducted from 2002 to 2022, and articles with the highest certainty evidence were selected. A strength rating has been provided for each recommendation according to the EAU Guideline Office methodology.<BR><B>UNASSIGNED: </B>Detrusor underactivity (DU) is a urodynamic diagnosis defined as a contraction of reduced strength and/or duration, resulting in prolonged bladder emptying and/or failure to achieve complete bladder emptying within a normal time span. UAB is a terminology that should be reserved for describing symptoms and clinical features related to DU. Invasive urodynamics is the only widely accepted method for diagnosing DU. In patients with persistently elevated postvoid residual (ie, >300 ml), intermittent catheterization is indicated and preferred to indwelling catheters. Alpha-adrenergic blockers are recommended before more invasive techniques, but the level of evidence is low. In men with DU and concomitant benign prostatic obstruction (BPO), benign prostatic surgery should be considered only after appropriate counseling. In men with DU and no BPO, a test phase of sacral neuromodulation may be considered.<BR><B>CONCLUSIONS: </B>The current text represents a summary of the new subchapter on UAB. For more detailed information, refer to the full-text version available on the EAU website (https://uroweb.org/guidelines/management-of-non-neurogenic-male-luts).